Mehrdad Abedi, MD
University of California, Davis
Professor of Hematology and Oncology
Mohammed Asmal, MD, PhD
Orbimed Healthcare Fund Management
Entrepreneur in Residence
David Avigan, MD
Cancer Center Director, Beth Israel Deaconess Medical Center
Chief, Division of Hematology and Hematologic Malignancies, Harvard Medical School
Professor of Medicine
David Brittan, MD
Alberts Stem Cell Transplant Center, Pretoria, South Africa
Head of Center
Joy Cavagnaro, PhD, DABT, Fellow ATS, RAC, RAPS Fellow
President
Access BIO, LC
Marina Cavazzana MD, PhD
Necker-Enfants Malades Hospital and the Imagine Institute
Professor of Hematology
Michael Chang, MPH
Adjuvant Capital
Principal
Kenneth Cornetta, MD
Indiana University, Indianapolis, USA
Professor of Clinical Medical & Molecular Genetics
Chris Danek, PhD, MBA
Catholic University of America, Washington D.C., USA
Distinguished Fellow and CEO, Bessel LLC
Lynda Dee, JD
Aids Action Baltimore
Executive Director
Steven Deeks, MD
University of California San Francisco, USA
Professor of Medicine
Stephanie Farnia, MPH
Nimitt Consulting (Health policy partners)
Principal
Mark Germain, JD
The Aentib Group
Managing Director
Sergio Giralt, MD. FACP, FASTCT
Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College
Deputy Head, Division of Hematologic Malignancies and Professor of Medicine
Bryon Johnson, PhD
Medical College of Wisconsin, Milwaukee, USA
Professor, Pediatrics (Hem/Onc), Micro. & Immunology
Geeta Jotwani, PhD
Department of Health Research / Ministry of Health & Family Welfare (Govt. of India)
Indian Council of Medical Research
Senior Deputy Director General (Scientist ‘G’)
Sadik Kassim, PhD
Danaher Corporation
Chief Technology Officer (Genomic Medicines)
Dominic Kemps, LLM, MSc, MA, MSc
Sommartel Ltd.
Chief Executive Officer
Hans-Peter Kiem, MD, PhD
Fred Hutch Cancer Center, Seattle, USA
Professor, Director, Stem Cell and Gene Therapy Program, Clinical Research Division
Cissy Kityo, MD
Joint Clinical Research Center, Kampala, Uganda
Executive Director
Sharon Lewin, FRACP, PHD, FAAHMS
The Peter Doherty Institute, Melbourne, Australia
Director of Institute
Marcos de Lima, MD
Ohio State University Medical Center, Columbus, USA
Division Chief, Hematology & Oncology
Franco Locatelli, MD
Sapienza, University of Rome, IRCCS Bambino Gesù Children’s Hospital
Director of the Department of Hematology and Oncology and Cell and Gene Therapy
Rocio Manghani, MPH
Gamida Cell
Sr Vice President, Market Access
Markus Maeurer, MD PhD FRCP (London)
Champalimaud Foundation and Johannes Gutenberg University of Mainz, Germany
Head ImmunoTherapy / ImmunoSurgery Cell Center
Michael Maschan, MD, PhD
Dmitry Rogachev National Medical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia
Director of the Department of Hematopoietic Stem Cell Transplantation
Vikram Matthews, MD
Christian Medical College, Vellore, India
Professor of Hematology
Rosemary Mazanet, MD, PhD
Cell One Partners
Strategic Advisor
Adrian McKemey, PhD
IQVIA, San Diego, USA
Managing Director and Head of R&D Strategy Solutions
David Miklos, MD, PhD
Stanford University, Palo Alto, USA
Chief of Bone Marrow Transplantation
Sam Murphy, PhD
Salubrius Biotherapeutics
Chief Executive Officer
Matthew Porteus, MD, PhD
Stanford University, Palo Alto, USA
Professor of Pediatrics
Avery D. Posey, Jr., PhD
University of Pennsylvania, USA
Assistant Professor, Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine
Florian Schuster, MBA
Bit Bio, Cambridge, UK
Chief Operating and Financial Officer
Rafick-Pierre Sekaly, PhD
Emory University, Atlanta, USA
Vice-Chair of Translational Medicine, Department of Pathology
Nirali N. Shah, MD, MHSc
National Cancer Institute, Bethesda, USA
Head, Hematologic Malignancies Section, Pediatric Oncology Branch
Jeff Sheehy
San Francisco, California, USA
Former CIRM Board Member & Patient Advocate
Elizabeth J Shpall, MD
MD Anderson Cancer Center, Houston, USA
Deputy Chair, Department of Stem Cell Transplantation and Cellular Therapy
John F. Tisdale, M.D.
National Institutes of Health
Senior Investigator and Director
Els Verhoeyen, PhD
Ens De Lyon, University of Lyon, Lyon & University Côte D’azur, Nice, France
Professor, INSERM Research Director
